Methods The T subsets and NK cell from peripheral blood of 60 patients with lung cancer, 15 patients with lung benign tumor and 15 healthy people were detected by immunofluorescence.
方法应用免疫荧光法检测60例肺癌患者、15例肺良性肿瘤患者和15例正常健康者外周静脉血T细胞亚群和NK细胞活性；
Found in 0.25% of general population, pulmonary hamartoma is the third most common cause of solitary pulmonary nodules and the most common benign tumor of the lung.
肺错构瘤在人群中发病率0.25%，是肺内孤立性结节的第三大常见的病因，也是肺内最为常见的良性肿瘤。
Conclusion Multiple tumor marker protein biochip detective system has high reliable practical value in differentiating diagnosis of benign and malignant lung lesion patients.
结论多肿瘤标志物蛋白芯片检测系统在肺良、恶性病变的鉴别诊断中有较高的应用价值。
Methods:The serums level of tumor markers were detected by the C-12 system in lung cancer patients with benign pulmonary disease and healthy persons.
方法：使用多肿瘤标志物蛋白芯片检测系统检测已确诊肺癌患者、肺部良性疾病和健康体检者的肿瘤标志物信息，并进行统计学分析。
Methods Serum tumor markers of lung cancer group, benign disease group and health control group were detected by chemiluminescence immunoassay (ECLIA).
方法采用电化学发光法(ECLIA)分别对肺癌组、肺部良性疾病组患者及健康人的血清肿瘤标记物浓度进行检测分析。
Methods Serum tumor markers of lung cancer group, benign disease group and health control group were detected by chemiluminescence immunoassay (ECLIA).
方法采用电化学发光法(ECLIA)分别对肺癌组、肺部良性疾病组患者及健康人的血清肿瘤标记物浓度进行检测分析。
应用推荐